Provivi

Provivi. Provivi is an agricultural biotechnology company that develops and manufactures pheromone-based solutions for crop protection. Founded in 2013, the company leverages fermentation technology to produce insect pheromones, offering an alternative to conventional chemical pesticides. Its products are designed to disrupt the mating cycles of major agricultural pests, providing a targeted and environmentally sustainable approach to integrated pest management.

Company overview

Provivi operates at the intersection of synthetic biology and sustainable agriculture, with its headquarters in Santa Monica, California. The company was co-founded by Nobel laureate Frances H. Arnold, along with Peter Meinhold and Pedro Coelho, who serves as its CEO. Its mission centers on reducing the ecological footprint of farming by providing effective, biodiversity-friendly pest control tools. The company's research and development activities are supported by a network of scientific advisors and collaborations with major institutions like the California Institute of Technology.

Technology and products

The core technology involves the use of engineered yeast strains in a proprietary fermentation process to biosynthesize insect pheromones. These pheromones are identical to the natural chemical signals insects use to locate mates. Provivi formulates these compounds into products, such as its Provivi FAW product for the fall armyworm, which are deployed in fields via dispensers. The mechanism, known as mating disruption, confuses male insects, preventing them from finding females and thereby reducing the pest population over generations. This approach is highly specific, affecting only the target insect species and leaving beneficial insects like pollinators unharmed.

Applications and impact

Provivi's products are primarily applied in large-scale row crop agriculture, including corn, soybean, and rice cultivation, targeting devastating pests like the fall armyworm and the Asian corn borer. By offering a non-toxic control method, the technology helps reduce reliance on broad-spectrum insecticides, mitigating issues such as pesticide resistance, water pollution, and harm to non-target organisms. This supports the principles of integrated pest management and can contribute to improved soil health and farm worker safety. The approach aligns with global sustainability goals and the demands of regenerative agriculture.

Partnerships and funding

The company has established significant partnerships with global leaders in the agricultural inputs sector. A major collaboration exists with Corteva Agriscience, which holds an equity stake and assists with the development, registration, and commercialization of Provivi's products worldwide. Provivi has secured substantial venture capital funding from investors including Temasek Holdings, Pontifax AgTech, and Kairos Ventures. These funds have supported the scaling of its manufacturing capabilities and the expansion of its field trial programs across key agricultural regions in North America, Latin America, and Asia.

History and development

Provivi originated from pioneering research in directed evolution conducted in the laboratory of Frances H. Arnold at the California Institute of Technology. The company was formally incorporated in 2013 to commercialize the fermentation-based production of pheromones, a breakthrough that addressed the historically high cost of chemically synthesizing these compounds. Key milestones include the opening of a multi-ton-scale production facility in 2019 and receiving the first regulatory approval for its fall armyworm product in Central America. The company continues to expand its product portfolio and pursue regulatory approvals in major agricultural markets globally.